Common Stock, Shares, Outstanding of REVIVA PHARMACEUTICALS HOLDINGS, INC. from 31 Aug 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
REVIVA PHARMACEUTICALS HOLDINGS, INC. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Aug 2018 to 30 Sep 2025.
  • REVIVA PHARMACEUTICALS HOLDINGS, INC. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 96,337,119, a 188% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

REVIVA PHARMACEUTICALS HOLDINGS, INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 96,337,119 +62,895,920 +188% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 68,003,613 +38,186,319 +128% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 46,739,949 +18,821,389 +67% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 46,579,199 +18,660,639 +67% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 33,441,199 +12,790,933 +62% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 29,817,294 +7,167,028 +32% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 27,918,560 +7,466,439 +37% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 27,918,560 +7,471,189 +37% 31 Dec 2023 10-K 03 Apr 2025 2024 FY
Q3 2023 20,650,266 +207,395 +1% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 22,650,266 +8,216,980 +57% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 20,452,121 +5,318,835 +35% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 20,447,371 +6,014,085 +42% 31 Dec 2022 10-K 15 Apr 2024 2023 FY
Q3 2022 20,442,871 +7,053,885 +53% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 14,433,286 +1,044,300 +7.8% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 15,133,286 +5,901,549 +64% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 14,433,286 +5,201,549 +56% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 13,388,986 +10,582,858 +377% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 13,388,986 +10,646,051 +388% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 9,231,737 +6,527,150 +241% 31 Mar 2021 10-Q 16 Aug 2021 2021 Q2
Q4 2020 9,231,737 +6,608,475 +252% 31 Dec 2020 10-K 15 Mar 2022 2021 FY
Q3 2020 2,806,128 +195,638 +7.5% 31 Aug 2020 10-Q 14 Oct 2020 2020 Q2
Q2 2020 2,742,935 +137,749 +5.3% 31 May 2020 10-Q 07 Jul 2020 2020 Q1
Q1 2020 2,704,587 +102,122 +3.9% 29 Feb 2020 10-Q 14 Jan 2021 2020 Q3
Q4 2019 2,623,262 +22,727 +0.87% 30 Nov 2019 10-Q 10 Jan 2020 2019 Q3
Q3 2019 2,610,490 +14,208 +0.55% 31 Aug 2019 10-Q 08 Oct 2019 2019 Q2
Q2 2019 2,605,186 31 May 2019 10-Q 03 Jul 2019 2020 Q1
Q1 2019 2,602,465 28 Feb 2019 10-K 04 May 2020 2020 FY
Q4 2018 2,600,535 30 Nov 2018 10-Q 09 Jan 2019 2019 Q3
Q3 2018 2,596,282 31 Aug 2018 10-Q 11 Oct 2018 2019 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.